A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico …
Abstract Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a global …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a global …
[HTML][HTML] Recent advances in developing small-molecule inhibitors against SARS-CoV-2
R Xiang, Z Yu, Y Wang, L Wang, S Huo, Y Li… - … Pharmaceutica Sinica B, 2022 - Elsevier
The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across
the entire world. Even though several COVID-19 vaccines are currently in distribution …
the entire world. Even though several COVID-19 vaccines are currently in distribution …
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
The chemical structure of PF-07321332, the first orally available Covid-19 clinical candidate,
has recently been revealed by Pfizer. No information has been provided about the …
has recently been revealed by Pfizer. No information has been provided about the …
[HTML][HTML] A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
[HTML][HTML] COVID-19 therapeutic options under investigation
M Kaddoura, M AlIbrahim, G Hijazi… - Frontiers in …, 2020 - frontiersin.org
Since its emergence in China in December 2019, COVID-19 has quickly spread around the
globe causing a pandemic. Vaccination or the development of herd immunity seems the only …
globe causing a pandemic. Vaccination or the development of herd immunity seems the only …
Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series
Background The COVID-19 pandemic caused by SARS-COV-2 began in Wuhan, China in
December 2019. Reports of COVID-19 with central (CNS) and peripheral nervous (PNS) …
December 2019. Reports of COVID-19 with central (CNS) and peripheral nervous (PNS) …
[HTML][HTML] COVID-19 at a glance: An up-to-date overview on variants, drug design and therapies
D Iacopetta, J Ceramella, A Catalano, C Saturnino… - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a member of the
Coronavirus family which caused the worldwide pandemic of human respiratory illness …
Coronavirus family which caused the worldwide pandemic of human respiratory illness …
Distance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID‐19
JB Liu, M Arockiaraj, M Arulperumjothi… - International Journal of …, 2021 - Wiley Online Library
The entire world is struggling to control the spread of coronavirus (COVID‐19) as there are
no proper drugs for treating the disease. Under clinical trials, some of the repurposed …
no proper drugs for treating the disease. Under clinical trials, some of the repurposed …
Potential role of interferons in treating COVID-19 patients
MH Abdolvahab, S Moradi-Kalbolandi, M Zarei… - International …, 2021 - Elsevier
The recently public health crises in the world is emerged by spreading the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) also named COVID-19. The virus is …
respiratory syndrome coronavirus 2 (SARS-CoV-2) also named COVID-19. The virus is …
Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19)
M Andrew, G Jayaraman - Carbohydrate Research, 2021 - Elsevier
The viral infection caused by SARS-CoV-2 has increased the mortality rate and engaged
several adverse effects on the affected individuals. Currently available antiviral drugs have …
several adverse effects on the affected individuals. Currently available antiviral drugs have …